Hepatitis D

Hepatitis D is an acute or chronic infection of the liver caused by an RNA virus, occurring either simultaneously with hepatitis B or as a superinfection in a hepatitis B carrier. It is usually more severe than other forms of hepatitis, is transmitted sexually or by exposure to infected blood or blood products.

Hepatitis D - most related articles:

- More cases of hepatitis D reported from Sabarkantha in Gujrat - 6.5
- Hepatitis B hits men harder than women due to an abnormal protein - 5.7
- HIV positive have good survival rate after liver transplant - 5.4
- New hope for hepatitis C sufferers - 4.9
- Incivek for hepatitis C infection is approved in US - 4.7
- Hepatitis C declines health with liver disease - 4.5
- New biomarker predicts response to hepatitis C treatment - 4.4
- Positive results of Albuferon in Chronic Hepatitis C - 3.9
- Obesity enhances liver cancer risk - 2.2
- A new drug may improve Hepatitis C - 2.2

Hepatitis D articles

35 new drugs approved in 2011 in US
Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin's lymphoma in 30 years; and the first new drug for lupus in 50 years.

Incivek for hepatitis C infection is approved in US
The U.S. Food and Drug Administration approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies.

A new drug may improve Hepatitis C
In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

Hepatitis B hits men harder than women due to an abnormal protein
Researchers are trying to explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than women.

New biomarker predicts response to hepatitis C treatment
Researchers at Duke University Medical Center have identified the first genetic marker that predicts response to hepatitis C treatments, and a single letter of DNA code appears to make a huge difference.

Positive results of Albuferon in Chronic Hepatitis C
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).

More cases of hepatitis D reported from Sabarkantha in Gujrat
Nearly dozen fresh cases of Hepatitis-D were reported from 3 different blocks of Sabarkantha district in Gujrat, where the liver disease has claimed 57 lives.

Hepatitis C declines health with liver disease
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.

New hope for hepatitis C sufferers
University of Adelaide virologists Dr Michael Beard and Dr Karla Helbig will work with colleagues from the University of NSW to develop new strategies to treat and prevent hepatitis C, which infects more than 170 million people around the world.

9 Hepatitis D articles listed above.

What is Hepatitis D
Hepatitis D is an acute or chronic infection of the liver caused by an RNA virus, occurring either simultaneously with hepatitis B or as a superinfection in a hepatitis B carrier. It is usually more severe than other forms of hepatitis, is transmitted sexually or by exposure to infected blood or blood products.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.16